Ginger Liau

Ginger Liau is a Partner in the Bio Fund at Andreessen Horowitz (a16z), a prominent venture capital firm.1 She focuses on biotech investments and leads business development for the a16z life sciences portfolio.12

Professional Background

Ginger's career spans both the biotechnology and investment sectors:

Current Role:: As a Partner at a16z, she specializes in biotech investments and portfolio company support.1

Previous Experience::

• MBA Operations Intern at Virta Health
• Investor Relations Senior Associate at Alnylam Pharmaceuticals
• Business Planning Analyst at Alnylam Pharmaceuticals
• RNA Synthesis Chemist at Alnylam Pharmaceuticals
• Clinical Scientist Intern at Shire Pharmaceuticals
• Research Assistant at Vanderbilt University4

Education

Ginger has a strong academic background in both business and science:

• MBA from Stanford University Graduate School of Business
• Bachelor's degree in Chemistry and Mathematics from Vanderbilt University3

Expertise and Responsibilities

At Andreessen Horowitz, Ginger's role involves:

1. Focusing on biotech investments within the Bio + Health team
2. Leading business development for the a16z life sciences portfolio
3. Supporting portfolio companies in areas such as partnership strategy and deal negotiations12

Her expertise in both the scientific and business aspects of biotechnology makes her well-suited to evaluate potential investments and assist portfolio companies in their growth and development.

Ginger Liau's LinkedIn profile can be found under the username ginger-liau-52149356, confirming her current position at Andreessen Horowitz.3